BioCentury
ARTICLE | Financial News

De Novo raises EUR27.3 million

July 26, 2001 7:00 AM UTC

Molecular design play De Novo Pharmaceuticals ( Cambridge, U.K.) raised EUR27.3 million ($24 million) in a VC round led by Merlin Biosciences Fund, which put up EUR7.3 million. New investors included ...